home / stock / mdxh / mdxh quote
Last: | $2.34 |
---|---|
Change Percent: | -3.0% |
Open: | $2.4 |
Close: | $2.34 |
High: | $2.4 |
Low: | $2.28 |
Volume: | 25,171 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.34 | $2.4 | $2.34 | $2.4 | $2.28 | 25,171 | 07-05-2024 |
$2.33 | $2.27 | $2.33 | $2.3899 | $2.26 | 8,011 | 07-04-2024 |
$2.33 | $2.27 | $2.33 | $2.3899 | $2.26 | 8,011 | 07-03-2024 |
$2.27 | $2.33 | $2.27 | $2.399 | $2.25 | 20,637 | 07-02-2024 |
$2.36 | $2.39 | $2.36 | $2.39 | $2.33 | 6,144 | 07-01-2024 |
$2.39 | $2.4 | $2.39 | $2.46 | $2.33 | 18,425 | 06-28-2024 |
$2.37 | $2.44 | $2.37 | $2.44 | $2.37 | 22,656 | 06-27-2024 |
$2.47 | $2.55 | $2.47 | $2.5853 | $2.39 | 26,583 | 06-26-2024 |
$2.5 | $2.56 | $2.5 | $2.59 | $2.5 | 10,387 | 06-25-2024 |
$2.56 | $2.6 | $2.56 | $2.6499 | $2.56 | 32,233 | 06-24-2024 |
$2.63 | $2.62 | $2.63 | $2.65 | $2.62 | 6,723 | 06-21-2024 |
$2.67 | $2.66 | $2.67 | $2.69 | $2.62 | 18,253 | 06-20-2024 |
$2.65 | $2.65 | $2.65 | $2.75 | $2.65 | 26,435 | 06-19-2024 |
$2.65 | $2.65 | $2.65 | $2.75 | $2.65 | 26,435 | 06-18-2024 |
$2.73 | $2.74 | $2.73 | $2.78 | $2.64 | 72,017 | 06-17-2024 |
$2.81 | $2.78 | $2.81 | $2.9399 | $2.73 | 74,337 | 06-14-2024 |
$2.82 | $2.8 | $2.82 | $2.99 | $2.77 | 98,346 | 06-13-2024 |
$2.89 | $2.88 | $2.89 | $2.89 | $2.82 | 6,904 | 06-12-2024 |
$2.87 | $2.78 | $2.87 | $2.87 | $2.7 | 18,261 | 06-11-2024 |
$2.8 | $2.87 | $2.8 | $2.87 | $2.77 | 21,794 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Mdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 ( GlobeNewswire ) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, ...
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 million Increasing 2024 revenue guidance to $83-85 million, previously $79-81 million Conference call with Q&A today at 08:30 AM ET / 14:30 CET ...
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a commercial-stage precision...